(Q50512818)

14 March 2018

title

A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group. (English)

1 reference

14 March 2018

1 reference

Meis J

1

1 reference

14 March 2018

Petrou M

2

1 reference

14 March 2018

Bille J

3

1 reference

14 March 2018

Ellis D

4

1 reference

14 March 2018

Gibbs D

5

1 reference

14 March 2018

publication date

1 April 2000

1 reference

14 March 2018

Diagnostic Microbiology and Infectious Disease

published in

1 reference

14 March 2018

volume

36

1 reference

14 March 2018

issue

4

1 reference

14 March 2018

page(s)

215-223

1 reference

14 March 2018

Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Fluconazole Global Susceptibility Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900152-2

7 January 2021

Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900152-2

7 January 2021

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900152-2

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900152-2

7 January 2021

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900152-2

7 January 2021

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900152-2

7 January 2021

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900152-2

7 January 2021

Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900152-2

7 January 2021

Fluconazole treatment of candidal infections caused by non-albicans Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900152-2

7 January 2021

10.1016/S0732-8893(99)00152-2

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

10764963

1 reference

14 March 2018